Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Mar;38(2):541-550.
doi: 10.1007/s40620-024-02160-x. Epub 2024 Dec 17.

Monoclonal gammopathy is present in one fourth of patients undergoing renal biopsy but is pathogenic only in half of them

Marco Allinovi  1 , Lorenzo Aterini  2   3 , Leonardo Caroti  2 , Giulia Antognoli  2 , Calogero Lino Cirami  2
Affiliations
Observational Study

Monoclonal gammopathy is present in one fourth of patients undergoing renal biopsy but is pathogenic only in half of them

Marco Allinovi et al. J Nephrol. 2025 Mar.

Abstract

Background: About 4-7% of renal biopsies show a monoclonal gammopathy-related nephropathy, such as AL amyloidosis, cast nephropathy, or light chain deposition disease. Both a high prevalence and a causal role of monoclonal gammopathy have been observed in patients with C3 glomerulopathy or thrombotic microangiopathy, although a definitive causative role cannot be established in most cases (potentially monoclonal gammopathy-related nephropathies). A coexisting monoclonal gammopathy has been identified in many cases of nephropathy without a defined causative role (monoclonal gammopathy-unrelated nephropathies). The aim of this study was to investigate the prevalence and distribution of monoclonal gammopathy in patients who underwent a renal biopsy and assess its possible causal role in nephropathies not ordinarily related to monoclonal gammopathy.

Methods: In our single-center retrospective observational study, we considered patients who underwent native kidney biopsy from 2009 to 2023 at the Nephrology Unit, Careggi University Hospital, Florence (Italy) and for whom a complete monoclonal gammopathy workup (serum electrophoresis, serum and urinary immunofixation, serum free light chains) was available.

Results: Overall, 827 patients were included: 208 (25%) had a monoclonal gammopathy: in 104 cases the monoclonal gammopathy was unrelated to the kidney disease; 87 subjects showed renal pathology related to monoclonal gammopathy (monoclonal gammopathy-related nephropathies). Patients with thrombotic microangiopathy and C3 glomerulopathy (potentially monoclonal gammopathy-related nephropathies) exhibited a prevalence of monoclonal gammopathy > 30%. In a subgroup of diagnoses (e.g. tubulointerstitial nephritis, membranoproliferative glomerulonephritis) a possible causal and/or prognostic role of a concomitant monoclonal gammopathy may be hypothesized.

Conclusions: In our cohort, one fourth of patients undergoing a renal biopsy had a monoclonal gammopathy, although in half of them the monoclonal gammopathy did not have a causative role in the kidney disease. Hence, it is impossible to conclude that a monoclonal gammopathy in the context of renal disease equates to a causal association without performing a renal biopsy because of the high frequency of monoclonal gammopathy in patients undergoing a kidney biopsy.

Keywords: C3 Glomerulopathy; MGRS; Monoclonal gammopathy; Renal biopsy; Thrombotic microangiopathy.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: All authors declare no conflicts of interest. Ethical approval: The study protocol conformed to the Declaration of Helsinki and was approved by a local research ethics committee (study approval number 22865_bio). Human and animal rights: The present study complies with the guidelines for human studies. This study does not contain any studies with animals. Informed consent: Informed written consent was obtained from all subjects involved in the study.

References

    1. Kyle RA, Rajkumar SV (2006) Monoclonal gammopathy of undetermined significance. Br J Haematol 134:573–589. https://doi.org/10.1111/j.1365-2141.2006.06235.x - DOI - PubMed
    1. Paueksakon P, Revelo MP, Horn RG, Shappell S, Fogo AB (2003) Monoclonal gammopathy: significance and possible causality in renal disease. Am J Kidney Dis 42:87–95. https://doi.org/10.1016/s0272-6386(03)00412-8 - DOI - PubMed
    1. Atkin C, Reddy-Kolanu V, Drayson MT, Sapey E, Richter AG (2020) The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions. Br J Haematol 189:1127–1135. https://doi.org/10.1111/bjh.16487 - DOI - PubMed
    1. Leung N, Bridoux F, Batuman V et al (2019) The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol 15:45–59. https://doi.org/10.1038/s41581-018-0077-4 - DOI - PubMed
    1. Sethi S, Rajkumar SV, D’Agati VD (2018) The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases. J Am Soc Nephrol 29:1810–1823. https://doi.org/10.1681/ASN.2017121319 - DOI - PubMed - PMC

Publication types

LinkOut - more resources